Completion of 5-year adjuvant endocrine therapy in the community

被引：0
|
作者：
Makubate, B. [1 ]
Thompson, A. M. [1 ]
Dewar, J. A. [2 ,3 ]
McCowan, C. [1 ]
机构：
[1] Univ Dundee, Dundee DD1 4HN, Scotland
[2] Ninewells Hosp, Dundee DD1 9SY, Scotland
[3] Sch Med, Dundee, Scotland
来源：
BREAST CANCER RESEARCH | 2010年 / 12卷
关键词：
Breast Cancer; Tamoxifen; Hospital Discharge; Eligible Patient; Incident Cancer;
D O I：
10.1186/bcr2551
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S16 / S17
页数：2
相关论文
共 50 条
  • [1] Completion of 5-year adjuvant endocrine therapy in the community
    B Makubate
    AM Thompson
    JA Dewar
    C McCowan
    [J]. Breast Cancer Research, 12
  • [2] Completion of 5-Years Adjuvant Endocrine Therapy in the Community
    Makubate, B.
    McCowan, C.
    Dewar, J. A.
    Thompson, A. M.
    [J]. CANCER RESEARCH, 2010, 70
  • [3] Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer
    Pagan, Eleonora
    Ruggeri, Monica
    Bianco, Nadia
    Bucci, Eraldo Oreste
    Graffeo, Rossella
    Borner, Markus
    Giordano, Monica
    Gianni, Lorenzo
    Rabaglio, Manuela
    Freschi, Andrea
    Cretella, Elisabetta
    Seles, Elena
    Farolfi, Alberto
    Simoncini, Edda
    Ciccarese, Mariangela
    Rauch, Daniel
    Favaretto, Adolfo
    Honecker, Friedemann
    Berardi, Rossana
    Franzetti-Pellanda, Alessandra
    Gelber, Shari
    Partridge, Ann H.
    Goldhirsch, Aron
    Bagnardi, Vincenzo
    Pagani, Olivia
    Ribi, Karin
    [J]. BREAST, 2024, 77
  • [4] Adherence to adjuvant endocrine therapy in postmenopausal breast cancer patients: A 5-year prospective study
    Hagen, Kari Britt
    Aas, Turid
    Kvaloy, Jan Terje
    Soiland, Hdvard
    Lind, Ragna
    [J]. BREAST, 2019, 44 : 52 - 58
  • [5] EARLY COMPLETION OF 5-YEAR PLAN TASKS
    不详
    [J]. NEFTYANOE KHOZYAISTVO, 1986, (01): : 3 - 5
  • [6] EARLY COMPLETION OF THE TARGETS OF THE 5-YEAR PLAN
    ALESHIN, GG
    [J]. GLASS AND CERAMICS, 1979, 36 (1-2) : 3 - 4
  • [7] Adherence to adjuvant endocrine therapy in postmenopausal breast cancer patients: A 5-year prospective study (vol 44, pg 52, 2019)
    Hagen, Kari Britt
    Aas, Turid
    Kvaloy, Jan Terje
    Soiland, Havard
    Lindb, Ragna
    [J]. BREAST, 2019, 45 : 118 - 118
  • [8] ADJUVANT ENDOCRINE THERAPY, CYTO-TOXIC CHEMOTHERAPY, AND IMMUNOTHERAPY IN STAGE-II BREAST-CANCER - 5-YEAR RESULTS
    PEARSON, OH
    HUBAY, CA
    MARSHALL, JS
    GORDON, NH
    MCGUIRE, WL
    MANSOUR, EG
    HERMANN, RE
    JONES, JC
    FLYNN, WJ
    ECKERT, C
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1983, 3 : S61 - S68
  • [9] Ibutilide Therapy for Atrial Fibrillation: 5-Year Experience in a Community Hospital
    Giudici, Michael C.
    Fischer, William J., III
    Cervantes, David C.
    Schrumpf, Phillip E.
    Paul, Deborah L.
    Sentman, Kristin E.
    Serra, Victoria L.
    Barold, S. Serge
    [J]. JOURNAL OF CARDIOVASCULAR NURSING, 2008, 23 (06) : 484 - 488
  • [10] 5-year adherence to adjuvant endocrine therapy among women with breast cancer: A nationwide study using group-based trajectory modeling
    Memoli, V.
    Lailler, G.
    Le Bihan-Bejamin, C.
    Bendiane, M. K.
    Lauzier, S.
    Mancini, J.
    Bousquet, P-J.
    Bouhnik, A-D.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 667 - 667
12345